Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome

Bommelaer G, Rouch M, Dapoigny M, Pais D, Loisy P, Gualino M, Tournut R. Epidémiologie des troubles fonctionnels intestinaux dans une population apparemment saine. Gastroenterol Clin Biol 10:7–12, 1986

Buéno L, Fioramonti J, Ruckebusch Y, Frexinos J, Colom P. Evaluation of colonic myoelectrical activity in health and functional disorders. Gut 21:480–485, 1980

Kellow JE, Phillips SF: Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 92:1885–1893, 1987

Lind CD: Motility disorders in the irritable bowel syndrome. Gastroenterol Clin North Am 20:279–295, 1991

Ritchie J: Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 14:125–132, 1973

Read NW: Irritable bowel syndrome (IBS)—definition and pathophysiology. Scand J Gastroenterol Suppl 130:7–13, 1987

Wingate DL: The irritable bowel syndrome. Gastroenterol Clin North Am 20:351–362, 1991

Diop L, Rivière P, Pascaud X, Junien JL: Peripheral kappa opioid receptors mediate the antinociceptive effect of fedotozine on the duodenal pain reflex in rat. Eur J Pharmacol 271:65–71, 1994

Rivière PJM, Pascaud X, Chevalier E, Le Gallou B, Junien JL: Fedotozine reverses ileus induced by surgery or peritonitis: Action at peripheral kappa opioid receptors. Gastroenterology 104:724–731, 1993

Rivière PJM, Pascaud X, Chevalier E, Junien JL: Fedotozine reversal of peritoneal irritation-induced ileus in rats: Possible peripheral action on sensory afferents. J Pharmacol Exp Ther 270:846–850, 1994

Gué M, Junien JL, Pascaud X, Bueno L: Antagonism of stress-induced motor alteration and plasma cortisol release by fedotozine (JO 1196) in dogs. J Gastrointest Motil 2:258–264, 1990

Gué M, Junien JL, Buéno L: The kappa agonist fedotozine modulates colonic distension-induced inhibition of gastric motility and emptying in dogs. Gastroenterology 107:1327–1334, 1994

Coffin B, Jian R, Lémann M, Fraitag B, Van Egroo LD, Franchisseur C, Rambauc JC: Fedotozine increases threshold of discomfort to gastric distension in healthy subjects. Gastroenterology 102:A437, 1992 (abstract)

Fraitag B, Homerin M, Hecketsweiler P: Double-blind doseresponse multicenter comparison of fedotozine and placebo in the treatment of nonulcer dyspepsia. Dig Dis Sci 39:1072–1077, 1994

Talley NJ, Piper DW: The association between nonulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol 20:896–900, 1985

Kirk RE: Experimental Design: Procedures for the Behavioral Sciences. 2nd ed. Pacific Grove, California, Brooks/Cole Publishing, 1982

Pattee PL, Thompson WG: Drug treatment of the irritable bowel syndrome. Drugs 44:200–206, 1992

Heaton KW, O'Donnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ: Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters. Gastroenterology 102:1962–1967, 1992

Manning AP, Thompson WG, Heaton KW, Lorris AF: Towards positive diagnosis of the irritable bowel. Br Med J 2:653–654, 1978

Talley NJ, Nyren O, Drossman DA, Heaton KW, Veldhuyzen van Zanten SJO, Koch MM, Ransohoff DF: The irritable bowel syndrome: Toward optimal design of controlled treatment trials. Gastroenterol Int 6:189–211, 1993